arginyl-glycyl-aspartic acid has been researched along with Chronic Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, I | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Antifibrogenic therapies in chronic HCV infection.
Topics: Antioxidants; Hepatitis C, Chronic; Hepatocyte Growth Factor; Hepatocytes; Humans; Interferons; Liver Cirrhosis; Oligopeptides; Retinoids; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta | 2001 |